XML 20 R7.htm IDEA: XBRL DOCUMENT v3.23.3
Consolidated Statement of Changes in Equity - USD ($)
$ in Thousands
Total
UNITED STATES
UNITED KINGDOM
BRAZIL
Outside the United States
Cumulative Effect, Period of Adoption, Adjusted Balance
Common Stock
Common Stock
Cumulative Effect, Period of Adoption, Adjusted Balance
Additional Paid-in Capital
Additional Paid-in Capital
Cumulative Effect, Period of Adoption, Adjusted Balance
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjusted Balance
Accumulated Other Comprehensive (Loss)
Accumulated Other Comprehensive (Loss)
Cumulative Effect, Period of Adoption, Adjusted Balance
Noncontrolling Interest
Noncontrolling Interest
Cumulative Effect, Period of Adoption, Adjusted Balance
Beginning balance (in shares) at Dec. 31, 2021             41,008,000                  
Beginning balance at Dec. 31, 2021 $ 1,324,837           $ 410   $ 0   $ 1,552,845   $ (266,909)   $ 38,491  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Net income 34,618                   39,972       (5,354)  
Currency translation adjustments 12,270                       4,780   7,490  
Cash flow hedges 18,580                       18,580      
Debt securities available-for-sale (160)                       (160)      
Repurchase and cancellation of common stock (shares)             860,000                  
Repurchase and cancellation of common stock (39,454)           $ (9)   4,527   (43,972)          
Vesting of restricted stock (in shares)             262,000                  
Vesting of restricted stock 0           $ 3   (3)              
Share-based compensation expense 3,891               3,891              
Employee stock relinquished for payment of taxes (8,415)               (8,415)              
Ending balance (in shares) at Mar. 31, 2022             40,410,000                  
Ending balance at Mar. 31, 2022 1,346,167           $ 404   0   1,548,845   (243,709)   40,627  
Beginning balance (in shares) at Dec. 31, 2021             41,008,000                  
Beginning balance at Dec. 31, 2021 1,324,837           $ 410   0   1,552,845   (266,909)   38,491  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Cash flow hedges 44,007                              
Debt securities available-for-sale (269)                              
Ending balance (in shares) at Sep. 30, 2022             38,976,000                  
Ending balance at Sep. 30, 2022 1,182,589           $ 389   0   1,557,066   (426,086)   51,220  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Changes in estimated recoveries 134,817                              
Revenues 743,674 $ 426,675 $ 126,866 $ 22,629 $ 167,504                      
Beginning balance (in shares) at Mar. 31, 2022             40,410,000                  
Beginning balance at Mar. 31, 2022 1,346,167           $ 404   0   1,548,845   (243,709)   40,627  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Net income 39,136                   36,484       2,652  
Currency translation adjustments (115,536)                       (109,707)   (5,829)  
Cash flow hedges 5,837                       5,837      
Debt securities available-for-sale (242)                       (242)      
Repurchase and cancellation of common stock (shares)             808,000                  
Repurchase and cancellation of common stock (34,935)           $ (8)   (3,835)   (31,092)          
Vesting of restricted stock (in shares)             37,000                  
Share-based compensation expense 3,849               3,849              
Employee stock relinquished for payment of taxes (14)               (14)              
Ending balance (in shares) at Jun. 30, 2022             39,639,000                  
Ending balance at Jun. 30, 2022 1,242,367           $ 396   0   1,554,237   (347,821)   35,555  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Distributions to noncontrolling interest (3,494)                           (3,494)  
Noncontrolling Interest, Increase From Contributions 1,599                           1,599  
Net income 27,182                   24,732       2,450  
Currency translation adjustments (91,390)                       (97,988)   6,598  
Cash flow hedges 19,590                       19,590      
Debt securities available-for-sale 133                       133      
Repurchase and cancellation of common stock (shares)             663,000                  
Repurchase and cancellation of common stock (25,001)           $ (7)   (3,091)   (21,903)          
Share-based compensation expense 3,101               3,101              
Employee stock relinquished for payment of taxes (10)               (10)              
Ending balance (in shares) at Sep. 30, 2022             38,976,000                  
Ending balance at Sep. 30, 2022 1,182,589           $ 389   0   1,557,066   (426,086)   51,220  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Changes in estimated recoveries 48,336                              
Distributions to noncontrolling interest (1,127)                           (1,127)  
Noncontrolling Interest, Increase From Contributions 7,744                           7,744  
Revenues 244,807 138,398 37,032 14,293 55,084                      
Long-Lived Assets $ 104,709 80,496 10,762 3 13,448                      
Beginning balance (in shares) at Dec. 31, 2022 38,980,000             38,980,000                
Beginning balance at Dec. 31, 2022 $ 1,286,750         $ 1,286,750   $ 390   $ 2,172   $ 1,573,025 (347,926) $ (347,926)   $ 59,089
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Net income (53,903)                   (58,629)       4,726  
Currency translation adjustments (1,550)                       (4,101)   2,551  
Cash flow hedges (4,831)                       (4,831)      
Debt securities available-for-sale 128                       128      
Vesting of restricted stock (in shares)             190,000                  
Vesting of restricted stock 0           $ 2   (2)              
Share-based compensation expense 3,799               3,799              
Employee stock relinquished for payment of taxes $ (5,684)               (5,684)              
Ending balance (in shares) at Mar. 31, 2023               39,170,000                
Ending balance at Mar. 31, 2023           1,224,709   $ 392   285   1,514,396   (356,730)   66,366
Beginning balance (in shares) at Dec. 31, 2022 38,980,000             38,980,000                
Beginning balance at Dec. 31, 2022 $ 1,286,750         1,286,750   $ 390   2,172   1,573,025 (347,926) (347,926)   59,089
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Cash flow hedges (6,772)                              
Debt securities available-for-sale $ 22                              
Ending balance (in shares) at Sep. 30, 2023 39,243,000             39,243,000                
Ending balance at Sep. 30, 2023 $ 1,189,987         1,189,987   $ 392   4,157   1,498,330 (387,289) (387,289)   74,397
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Changes in estimated recoveries 6,380                              
Revenues 581,136 258,848 99,547 69,383 153,358                      
Beginning balance (in shares) at Mar. 31, 2023               39,170,000                
Beginning balance at Mar. 31, 2023           1,224,709   $ 392   285   1,514,396   (356,730)   66,366
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Net income 1,160                   (3,804)       4,964  
Currency translation adjustments 7,083                       3,091   3,992  
Cash flow hedges 5,719                       5,719      
Debt securities available-for-sale (80)                       (80)      
Vesting of restricted stock (in shares)             72,000                  
Share-based compensation expense 2,715               2,715              
Employee stock relinquished for payment of taxes (459)               (459)              
Ending balance (in shares) at Jun. 30, 2023               39,242,000                
Ending balance at Jun. 30, 2023           1,239,674   $ 392   2,541   1,510,592 (348,000) (348,000)   74,149
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Distributions to noncontrolling interest (1,173)                           (1,173)  
Net income (8,151)                   $ (12,262)       4,111  
Currency translation adjustments (34,279)                       (31,603)   (2,676)  
Cash flow hedges (7,660)                       (7,660)      
Debt securities available-for-sale (26)                       (26)      
Vesting of restricted stock (in shares)             1,000                  
Share-based compensation expense 1,629               1,629              
Employee stock relinquished for payment of taxes $ (13)               $ (13)              
Ending balance (in shares) at Sep. 30, 2023 39,243,000             39,243,000                
Ending balance at Sep. 30, 2023 $ 1,189,987         $ 1,189,987   $ 392   $ 4,157   $ 1,498,330 $ (387,289) $ (387,289)   $ 74,397
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Changes in estimated recoveries 22,156                              
Distributions to noncontrolling interest (1,187)                           $ (1,187)  
Revenues 216,430 105,456 30,978 24,749 55,247                      
Long-Lived Assets $ 85,718 $ 61,788 $ 11,233 $ 3 $ 12,694